NEWAMSTERDAM PHARMA COMPANY NAMS
ORDINARY SHARES · Common Stock · CUSIP N62509109
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $11.89. Options: 1 managers hold calls ($3.4m notional), 0 hold puts (—).
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2022 | 15 |
| Q1 2023 | 20 |
| Q2 2023 | 30 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2023 | 12 | 3 |
| Q2 2023 | 24 | 2 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $0 | $0 | — |
| Q4 2022 | $0 | $0 | — |
| Q1 2023 | $3.8m | $0 | 0.00 |
| Q2 2023 | $3.4m | $0 | 0.00 |
Biggest buyers
| RA CAPITAL MANAGEMENT, L.P. | Added | +5.0m |
| VIKING GLOBAL INVESTORS LP | Added | +2.6m |
| Bain Capital Life Sciences Investors, LLC | Added | +2.2m |
| Frazier Life Sciences Management, L.P. | Added | +1.5m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New | +1.2m |
| Medicxi Ventures Management (Jersey) Ltd | Added | +869.6k |
| Eversept Partners, LP | Added | +646.5k |
| MILLENNIUM MANAGEMENT LLC | Added | +317.9k |
| GMT Capital Corp | Added | +300.0k |
| AXA S.A. | New | +224.4k |
Biggest sellers
| JPMORGAN CHASE & CO | Reduced | -10.9k |
| WOLVERINE ASSET MANAGEMENT LLC | Sold out | -4.8k |
Biggest calls
| Alyeska Investment Group, L.P. | Unchanged | $3.4m289.3k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Capital World Investors 13G · institution +1.7 pts · filed 2026-06-04 | 10.4% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor no change · filed 2025-05-15 | 9.9% |
| FMR LLC 13G · institution +1.2 pts · filed 2026-08-06 | 8.8% |
| Frazier Life Sciences X, L.P. 13D · may seek influence +1.0 pts · filed 2026-09-22 | 8.7% |
| Forbion Capital Fund IV Cooperatief U.A. 13D · may seek influence -1.1 pts · filed 2025-09-30 | 8.3% |
Fell to 5% or below in the last year: BCLS II Investco, LP (1.8%, 2026-05-14), VIKING GLOBAL INVESTORS LP (3.7%, 2026-02-17)
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Frazier Life Sciences Management, L.P. 7.72% of their portfolio | 10.9m $129.3m | Added +1.5m |
| Bain Capital Life Sciences Investors, LLC 12.83% of their portfolio | 10.5m $124.5m | Added +2.2m |
| RA CAPITAL MANAGEMENT, L.P. 2.02% of their portfolio | 9.0m $107.0m | Added +5.0m |
| VIKING GLOBAL INVESTORS LP 0.32% of their portfolio | 6.5m $77.6m | Added +2.6m |
| Medicxi Ventures Management (Jersey) Ltd 9.56% of their portfolio | 2.9m $34.1m | Added +869.6k |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.64% of their portfolio | 2.5m $30.1m | Unchanged |
| BVF INC/IL 0.50% of their portfolio | 1.5m $18.1m | Unchanged |
| GMT Capital Corp 0.62% of their portfolio | 1.4m $16.5m | Added +300.0k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.03% of their portfolio | 1.2m $14.3m | New |
| Eversept Partners, LP 0.87% of their portfolio | 692.4k $8.2m | Added +646.5k |
| Ensign Peak Advisors, Inc 0.01% of their portfolio | 442.0k $5.3m | Added +87.0k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 373.6k $4.4m | Added +317.9k |
| Parkman Healthcare Partners LLC 0.49% of their portfolio | 239.1k $2.8m | Added +124.1k |
| AXA S.A. 0.01% of their portfolio | 224.4k $2.7m | New |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 129.5k $1.5m | New |
| Affinity Asset Advisors, LLC 0.47% of their portfolio | 100.0k $1.2m | New |
| Monashee Investment Management LLC 0.27% of their portfolio | 95.0k $1.1m | New |
| Schonfeld Strategic Advisors LLC 0.01% of their portfolio | 57.3k $681.3k | Added +27.2k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 25.8k $306.4k | Added +7.2k |
| MARSHALL WACE, LLP 0.00% of their portfolio | 25.4k $301.5k | New |
| Maven Securities LTD 0.04% of their portfolio | 25.0k $297.2k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 11.5k $136.3k | Reduced -10.9k |
| Venture Visionary Partners LLC 0.01% of their portfolio | 10.0k $118.9k | New |
| MORGAN STANLEY 0.00% of their portfolio | 808 $9.6k | Added +305 |
| Cutler Group LLC / CA 0.00% of their portfolio | 500 $5.0k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 300 $3.6k | New |
| UBS Group AG 0.00% of their portfolio | 183 $2.2k | New |
| ATTICUS WEALTH MANAGEMENT, LLC 0.00% of their portfolio | 166 $2.0k | Unchanged |
| DUPONT CAPITAL MANAGEMENT CORP 0.00% of their portfolio | 1 $12 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |